NPR's Jon Hamilton reports on the 20-year patents Canada gives to pharmaceutical companies. The wealthy firms have powerful influence over which drugs are developed, and who can get them. The issue is at the center of a contentious trial in South Africa over that country's laws which allow generic drugs for AIDS.
Copyright 2001 NPR
